产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
CAS No. |
835621-11-9 |
|---|---|
中文名称 |
瑞戈非尼杂质 13 |
英文名称 |
4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-2-(methylcarbamoyl)pyridine 1-oxide |
别名 |
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide;Regorafenib N-Oxide (M2 Metabolite);Regorafenib N-Oxide(M2);Regorafenib N-Oxide;Regorafenib impurity M;Regorafenib Pyridine-N-Oxide;Regorafénib N-oxyde (M2);2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, 1-oxide |
标准英文名 |
4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-2-(methylcarbamoyl)pyridine 1-oxide |
分子式 |
C21H15ClF4N4O4 |
分子量 |
498.82 |
精确分子量 |
498.07 |
SMILES |
O=C(C1=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C(F)=C2)=CC=[N+]1[O-])NC |
标准SMILES |
CNC(=O)C1=CC(=CC=[N+]1[O-])OC1C=C(F)C(=CC=1)NC(=O)NC1C=C(C(Cl)=CC=1)C(F)(F)F |
性状 |
White to light yellow powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
NUCXNEKIESREQY-UHFFFAOYSA-N |
危险类别(旧) |
H302,H361,H373 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Reproductive toxicity (Category 2),Specific target organ toxicity, repeated exposure (Category 2) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|